Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Peter L. Greenberg(Stanford University), Courtney Smith, Aref Al‐Kali(Mayo Clinic), Amir T. Fathi(University of Southern California), Rami S. Komrokji(Moffitt Cancer Center), Olga Frankfurt, H. Joachim Deeg(Fred Hutch Cancer Center), Hetty E. Carraway(Cleveland Clinic), Stefan K. Barta(University of Pennsylvania), Brady L. Stein(Barnes-Jewish Hospital), Daniel A. Pollyea(University of Colorado Denver), Amy E. DeZern(Johns Hopkins University), Robert A. Johnson(Arizona State University), Virginia M. Klimek(Memorial Sloan Kettering Cancer Center), Lori J. Maness(Susan Thompson Buffett Foundation), Elizabeth A. Griffiths(Roswell Park Comprehensive Cancer Center), Guillermo Garcia‐Manero(The University of Texas MD Anderson Cancer Center), Rafael Bejar(UC San Diego Health System), John M. Bennett(University of Rochester Medical Center), Amer M. Zeidan(Yale Cancer Center), Richard M. Stone(Dana-Farber Cancer Institute), Dorothy A. Shead(University of the Witwatersrand), Ruth Horsfall, Paul J. Shami(University of Utah), Alison R. Walker(The Ohio State University), Peter Westervelt(MACOM (United States)), Carlos M. de Castro(Barnes-Jewish Hospital), Margaret O’Donnell(City Of Hope National Medical Center), Karin Gaensler(University of California, San Francisco), David Head, Mark Juckett(University of Wisconsin–Madison), Lisa Kujawski
Cited by 297
Related Papers
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|1.6k
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k